Peter is a highly regarded, business-minded, financial professional with over 35 years of diversified experience in the US and Europe. He has the ability to synthesize complex issues to produce and implement value enhancing solutions to drive improved profit and cash flow. Peter is energetic, articulate and excellent at presenting his vision to employees, senior executives and stakeholders. His approach has created substantial value for the firms he has worked with.

Peter started his professional career with the International Top 4 accounting firm, KPMG, gaining experience in a wide variety of industries. From there he moved to ICI, one of the leading UK companies, where he progressed through increasingly senior roles in operations and finance ending as head of finance for corporate planning of the Pharmaceuticals where he led numerous acquisitions and divestments while producing the long-term strategic forecasts for the business.

Peter became CFO of Aptium Oncology, the Los Angeles based leading manager of cancer centers in 1997. During his 15 years he transformed Aptium from loss making into an extremely profitable company by building a highly regarded, motivated finance team and with their help introducing focused reporting systems which enabled management to concentrate on the key issues to drive revenue, profit and cash flow. He is skilled negotiator whose efforts helped Aptium achieve industry-leading margins. He led the disposal of Aptium and through his innovative approach generated over 600% of the value offered by Private Equity.

Peter received a masters from Oxford University and successfully completed the Advanced Management Program at Duke. He qualified as a Chartered Accountant and is a now Fellow Of the Institute of Chartered Accountants. He is married with 2 children and lives in Pacific Palisades, California.